572913-59-8 Usage
Uses
Used in Pharmaceutical Research:
Hexanoic acid, 6-[[(2-cyanoethoxy)[(4,4-diphenylcyclohexyl)oxy]phosphinyl]oxy]-, ethyl ester is used as a research compound for the development of new pharmaceuticals due to its unique structure and properties.
Used in Agrochemicals:
Hexanoic acid, 6-[[(2-cyanoethoxy)[(4,4-diphenylcyclohexyl)oxy]phosphinyl]oxy]-, ethyl ester is used in the development of agrochemicals, where it may have potential applications in pest control or crop protection.
Used in Materials Science:
Hexanoic acid, 6-[[(2-cyanoethoxy)[(4,4-diphenylcyclohexyl)oxy]phosphinyl]oxy]-, ethyl ester is used in materials science for the development of new materials with unique properties, such as improved stability or reactivity.
Further research is being conducted to explore the potential uses and benefits of Hexanoic acid, 6-[[(2-cyanoethoxy)[(4,4-diphenylcyclohexyl)oxy]phosphinyl]oxy]-, ethyl ester in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 572913-59-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,2,9,1 and 3 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 572913-59:
(8*5)+(7*7)+(6*2)+(5*9)+(4*1)+(3*3)+(2*5)+(1*9)=178
178 % 10 = 8
So 572913-59-8 is a valid CAS Registry Number.
572913-59-8Relevant academic research and scientific papers
Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo
Zobel, Kerry,Koehler, Michael F. T.,Beresini, Maureen H.,Caris, Lisa D.,Combs, Daniel
, p. 1513 - 1515 (2007/10/03)
A series of phosphate ester based small molecules designed to bind tightly to serum albumin were applied to the amino terminus of an anticoagulant peptide in an effort to increase its protein binding in vivo. The tagged peptides exhibited high affinity for both rabbit and human serum albumin when passed through liquid chromatographic columns with serum albumins incorporated into the stationary phase. The peptides were then administered intravenously to rabbits and found to have a greater than 50-fold increase in plasma half life. The highest affinity peptides showed a reduction in bioactivity consistent with their sequestration away from their protein target in the presence of 0.1% rabbit serum albumin.
